Gut Mucosal and Fecal Microbiota Profiling Combined to Intestinal Immune System in Neonates Affected by Intestinal Ischemic Injuries

Background and Purpose: Early life microbiota plays a crucial role in human health by acting as a barrier from pathogens' invasion and maintaining the intestinal immune homoeostasis. Altered fecal microbiota (FM) ecology was reported in newborns affected by intestinal ischemia. Our purpose was...

Full description

Bibliographic Details
Main Authors: Lorenza Romani, Federica Del Chierico, Maria Chiriaco, Silvia Foligno, Sofia Reddel, Guglielmo Salvatori, Cristina Cifaldi, Simona Faraci, Andrea Finocchi, Paolo Rossi, Pietro Bagolan, Patrizia D'Argenio, Lorenza Putignani, Fabio Fusaro
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcimb.2020.00059/full
id doaj-6197592dc57c498983c91e38f58aa2d1
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Lorenza Romani
Federica Del Chierico
Maria Chiriaco
Silvia Foligno
Sofia Reddel
Guglielmo Salvatori
Cristina Cifaldi
Simona Faraci
Andrea Finocchi
Paolo Rossi
Pietro Bagolan
Patrizia D'Argenio
Lorenza Putignani
Fabio Fusaro
spellingShingle Lorenza Romani
Federica Del Chierico
Maria Chiriaco
Silvia Foligno
Sofia Reddel
Guglielmo Salvatori
Cristina Cifaldi
Simona Faraci
Andrea Finocchi
Paolo Rossi
Pietro Bagolan
Patrizia D'Argenio
Lorenza Putignani
Fabio Fusaro
Gut Mucosal and Fecal Microbiota Profiling Combined to Intestinal Immune System in Neonates Affected by Intestinal Ischemic Injuries
Frontiers in Cellular and Infection Microbiology
intestinal ischemia
mucosal microbiota
fecal microbiota
intestinal immune system
microbial markers
author_facet Lorenza Romani
Federica Del Chierico
Maria Chiriaco
Silvia Foligno
Sofia Reddel
Guglielmo Salvatori
Cristina Cifaldi
Simona Faraci
Andrea Finocchi
Paolo Rossi
Pietro Bagolan
Patrizia D'Argenio
Lorenza Putignani
Fabio Fusaro
author_sort Lorenza Romani
title Gut Mucosal and Fecal Microbiota Profiling Combined to Intestinal Immune System in Neonates Affected by Intestinal Ischemic Injuries
title_short Gut Mucosal and Fecal Microbiota Profiling Combined to Intestinal Immune System in Neonates Affected by Intestinal Ischemic Injuries
title_full Gut Mucosal and Fecal Microbiota Profiling Combined to Intestinal Immune System in Neonates Affected by Intestinal Ischemic Injuries
title_fullStr Gut Mucosal and Fecal Microbiota Profiling Combined to Intestinal Immune System in Neonates Affected by Intestinal Ischemic Injuries
title_full_unstemmed Gut Mucosal and Fecal Microbiota Profiling Combined to Intestinal Immune System in Neonates Affected by Intestinal Ischemic Injuries
title_sort gut mucosal and fecal microbiota profiling combined to intestinal immune system in neonates affected by intestinal ischemic injuries
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2020-02-01
description Background and Purpose: Early life microbiota plays a crucial role in human health by acting as a barrier from pathogens' invasion and maintaining the intestinal immune homoeostasis. Altered fecal microbiota (FM) ecology was reported in newborns affected by intestinal ischemia. Our purpose was to describe, in these patients, the FM, the mucosal microbiota (MM) and the mucosal immunity.Methods: Fourteen newborns underwent intestinal resection because of intestinal ischemia. FM and MM were determined through targeted-metagenomics, diversity assignment and Kruskal-Wallis analyses of Operational taxonomic units (OTUs). The mucosal immune cells were analyzed through cytofluorimetry.Results and Conclusion: Based on the severity intestinal injueris we identified two groups: extensive (EII) and focal intestinal ischemia (FII). FM and MM varied in EII and FII groups, showing in the EII group the predominance of Proteobacteria and Enterobacteriaceae and the reduction of Bacteroidetes and Verrucomicrobia for both microbiota. The MM was characterized by a statistically significant reduction of Bacteroides, Lachnospiraceae and Ruminococcaceae and by a higher diversity in the EII compared to FII group. FM showed a prevalence of Proteobacteria, while the Shannon index was lower in the EII compared to FII group. An overall increment in B- and T-lymphocytes and Natural killer (NK) T-like cells was found for EII mucosal samples associated to an increment of TNF-α and INF-γ expressing cells, compared to FII group. FM and MM carry specific signatures of intestinal ischemic lesions. Further research may be crucial to address the role of specific taxa in EII, expecially with reference to inflammation grade and ischemia extension.
topic intestinal ischemia
mucosal microbiota
fecal microbiota
intestinal immune system
microbial markers
url https://www.frontiersin.org/article/10.3389/fcimb.2020.00059/full
work_keys_str_mv AT lorenzaromani gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT federicadelchierico gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT mariachiriaco gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT silviafoligno gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT sofiareddel gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT guglielmosalvatori gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT cristinacifaldi gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT simonafaraci gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT andreafinocchi gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT paolorossi gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT pietrobagolan gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT patriziadargenio gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT lorenzaputignani gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
AT fabiofusaro gutmucosalandfecalmicrobiotaprofilingcombinedtointestinalimmunesysteminneonatesaffectedbyintestinalischemicinjuries
_version_ 1724911196420702208
spelling doaj-6197592dc57c498983c91e38f58aa2d12020-11-25T02:12:09ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882020-02-011010.3389/fcimb.2020.00059505024Gut Mucosal and Fecal Microbiota Profiling Combined to Intestinal Immune System in Neonates Affected by Intestinal Ischemic InjuriesLorenza Romani0Federica Del Chierico1Maria Chiriaco2Silvia Foligno3Sofia Reddel4Guglielmo Salvatori5Cristina Cifaldi6Simona Faraci7Andrea Finocchi8Paolo Rossi9Pietro Bagolan10Patrizia D'Argenio11Lorenza Putignani12Fabio Fusaro13Division of Immunology and Infectious Diseases, University-Hospital Pediatric Department (DPUO), Bambino Gesù Children's Hospital, IRCSS, Rome, ItalyUnit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDivision of Immunology and Infectious Diseases, University-Hospital Pediatric Department (DPUO), Bambino Gesù Children's Hospital, IRCSS, Rome, ItalyNeonatal Intensive Care Unit, Department of Medical and Surgical Neonatology, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyUnit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyNeonatal Intensive Care Unit, Department of Medical and Surgical Neonatology, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDivision of Immunology and Infectious Diseases, University-Hospital Pediatric Department (DPUO), Bambino Gesù Children's Hospital, IRCSS, Rome, ItalyDigestive Endoscopy and Surgery Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDivision of Immunology and Infectious Diseases, University-Hospital Pediatric Department (DPUO), Bambino Gesù Children's Hospital, IRCSS, Rome, ItalyDivision of Immunology and Infectious Diseases, University-Hospital Pediatric Department (DPUO), Bambino Gesù Children's Hospital, IRCSS, Rome, ItalyDepartment of Medical and Surgical Neonatology, Neonatal Surgery Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDivision of Immunology and Infectious Diseases, University-Hospital Pediatric Department (DPUO), Bambino Gesù Children's Hospital, IRCSS, Rome, ItalyUnit of Parasitology and Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDepartment of Medical and Surgical Neonatology, Neonatal Surgery Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyBackground and Purpose: Early life microbiota plays a crucial role in human health by acting as a barrier from pathogens' invasion and maintaining the intestinal immune homoeostasis. Altered fecal microbiota (FM) ecology was reported in newborns affected by intestinal ischemia. Our purpose was to describe, in these patients, the FM, the mucosal microbiota (MM) and the mucosal immunity.Methods: Fourteen newborns underwent intestinal resection because of intestinal ischemia. FM and MM were determined through targeted-metagenomics, diversity assignment and Kruskal-Wallis analyses of Operational taxonomic units (OTUs). The mucosal immune cells were analyzed through cytofluorimetry.Results and Conclusion: Based on the severity intestinal injueris we identified two groups: extensive (EII) and focal intestinal ischemia (FII). FM and MM varied in EII and FII groups, showing in the EII group the predominance of Proteobacteria and Enterobacteriaceae and the reduction of Bacteroidetes and Verrucomicrobia for both microbiota. The MM was characterized by a statistically significant reduction of Bacteroides, Lachnospiraceae and Ruminococcaceae and by a higher diversity in the EII compared to FII group. FM showed a prevalence of Proteobacteria, while the Shannon index was lower in the EII compared to FII group. An overall increment in B- and T-lymphocytes and Natural killer (NK) T-like cells was found for EII mucosal samples associated to an increment of TNF-α and INF-γ expressing cells, compared to FII group. FM and MM carry specific signatures of intestinal ischemic lesions. Further research may be crucial to address the role of specific taxa in EII, expecially with reference to inflammation grade and ischemia extension.https://www.frontiersin.org/article/10.3389/fcimb.2020.00059/fullintestinal ischemiamucosal microbiotafecal microbiotaintestinal immune systemmicrobial markers